DOCSLIB.ORG

Subject Index J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subject Index J Subject Index J. Neurosci., December 2009 • 29(1): •1 Subject Index A Actin-rich protrusive structure, 10995 extracellular signal-regulated kinase, 4228, 6955 Action. See also Behavior fibrillar amyloid ␤-stimulated microglial, 11982 A11 cell group neuron, 12532 ␥-aminobutyric acid, 6982 gamma, 13962 A117V transgenic mouse, 10072 aversion and, 15669 gamma-band electrocorticographic, 10203 AAV. See Adeno-associated virus countermanding, 9059 guanosine triphosphatase, 14534 A␤. See Amyloid goal-directed, 6154, 8280, 14617 homopentameric cysteine-loop receptor, 6022 ABCA1. See Adenosine triphosphate-binding cassette transporter past, 15669 human brain, 10563 A1 prefrontal dopamine and, 6599 hypothalamus-brainstem circuit, 8302 ABCG2, 5463 reelin, 10653 inhibition of, 13543, 13823 Abducens motoneuron, 575 transsynaptic, 9809 integrin, 12506 Aberrant frontoparietal function, 11347 Action choice, 13365, 14701 kinase, 5758, 7607 Ablation, conditional, 10869 Action goal, 11134 local field potential, 5354 Abnormal chemosensory jump 6, 12940 Action knowledge, 4922 locomotor, 4155, 13283 Abnormal involuntary movement, 4829 Action network, cortical, 4922 matrix metalloproteinase-9, 3508 Abnormal muscle spindle development, 4719 Action potential, 6897 maturation of, 12558 Abnormal water diffusion, 3508 backpropagating, 3233, 7803 memory and, 14463 Absence epilepsy, 2833 basal, 15586 metabotropic, 2890 Absence seizure, 371 repetitive postsynaptic, 11153 metabotropic glutamate receptor, 9281 Absence timing, 14383 Action potential phasing, 13353 N-methyl-D-aspartate receptor, 14581 Abstinent methylenedioxymethamphetamine, 14050 Action selection, 3148, 6105, 6926 microglia, 3781 Abundance, calcium ion channel, 10730 Action sequence chunking, 8280 miniature excitatory synaptic, 13222 Abuse, drug. See Drug, abuse of Action space, structured, 13524 motoneuron, 11732 AC. See Adenylyl cyclase Action value, 7489, 11182 motor, 9351 ACC. See Anterior cingulate cortex Activated leukocyte cell adhesion molecule, 15630 multisite local field potential, 5354 aCC. See Adenylate cyclase Activated N-methyl-D-aspartate receptor, 6819 neocortical network, 10890 Accessory olfactory bulb, 14211 Active input on dendrite, 6406 network, 328, 10890 Accumbens, nucleus. See Nucleus accumbens Active zone, 351, 517 neural (See Neural activity) Accumbens core, 12275 development of, 11484 neuritogenic, 3220 Accumbens shell, 1331, 12275 differentiation and, 5207 neuron, 591, 5616, 6691, 8871 Accumulation Activity/Activation, 2334, 2890, 2972, 3182, 3206, 3288, 3307, nicotinic adenine dinucleotide phosphate oxidase, 13823 at excitatory synapse, 4004 4155. See also Inactivation; specific types, e.g. Calcium- nucleus accumbens, 9582 psychosine, 6068 activated occupancy and, 6022 ACd. See Anterior cingulate cortex acetylcholine release and, 3808 opioid, 4293, 6500 Acetate, methylazoxymethanol, 2344 acid-sensing ion channel-1a, 14371 oscillatory, 9481 Acetylation, protein, 2824 afferent, 10025 p38 mitogen-activated protein kinase, 3518 Acetylcholine, 52, 1626 ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid re- pacemaker, 15414 extracellular, 3808 ceptor, 6308 pathway, 10299 Acetylcholine receptor, 842 ␥-aminobutyric acid receptor, 11650 performance-related, 11880 muscarinic, 14271, 14942 amygdala, 9123 periodic afferent, 10025 nicotinic (See Nicotinic acetylcholine receptor) amygdala opioid, 6500 peripheral, 8051 Acetylcholine release, 2272, 3808 amyloid ␤-induced calpain, 4640 persistent cortical, 7513 Acetylcholinesterase biosynthesis, 4519 anticipatory, 11880 place cell, 898 Acetylcholinesterase targeting, 4519 asynchronous neuron, 8871 prelimbic, 8474 Acetyltransferase, histone, 2824 ATPase, 12079 prestimulus, 2725 ACh. See Acetylcholine auditory cortical, 15898 proteolipid promotor, 7256 AChE. See Acetylcholinesterase autocrine, 12702 Rab3A guanosine triphosphatase, 14534 AChR. See Acetylcholine receptor autophagy, 13578 regulation of, 5276, 8129 Acid. See specific acid by name axotomy-induced Smad1, 7116 rest-related, 14463 Acidosis-induced neuron death, 14371 background, 10234 rhythmic motor, 9351 Acid-sensing ion channel 1a, 14371 biphasic, 7424 rostral shift in, 7166 in amygdala, 5381, 6053 brain, 8604, 10563, 14463, 14812 short-latency, 6336 depression and, 5381 brain glucose metabolic, 9961 slow-wave, 620 fear and, 6053 breathing, 5806 Sonic hedgehog, 10299 Acid-sensing ion channel 2, 8438 calcium-dependent chloride channel, 6809 spatiotemporal, 7166 Acj. See Abnormal chemosensory jump cannabinoid receptor, 11078 spike, 5062, 5276 Acoustically evoked discharge, 9510 cerebral, 7053 spike train, 10234 Acoustic communication, 2575 cerebrocortical, 15126 spinal neuron, 6691 Acoustic rate, 61 chemokine receptor, 8051 spontaneous, 8512, 9510, 14596 Acoustics, 454 cofilin, 8129 spontaneous bursting, 12131 Acquired channelopathy, 4430 contralateral, 6353, 8187 spontaneous calcium spike, 7877 Acquisition, 2762, 3302 correlated, 1077 state-dependent gamma, 13962 sequential, 6234 cortical (See Cortical activity) stimulus-induced gamma, 13962 of simple motor skill, 5784 cortical oscillatory, 9481 striatal network, 7540 ACTH. See Adrenocorticotrophic hormone corticostriatal, 2414 subthreshold, 15213 Actin, 550, 638, 863, 1586 decorrelation of, 10890 superior temporal sulcus, 4542 Actin cytoskeleton, 288, 10869 dopamine receptor, 6124, 10785 sustained, 6353, 11880 rearrangement of, 13971 dynamic, 10264 synaptic (See Synaptic activity) Actin depolymerization, 2926 electrical, 2167 synaptic N-methyl-D-aspartate, 4442 Actin-depolymerizing factor/cofilin, 12994 electrocorticographic, 10203 task-dependent, 13338 Actin filament, 15083 enzymatic, 5525 theta, 8094 Actin network interference, 12167 error-related, 7158 tonic, 11294 Actin rearrangement, 12244 excitatory synaptic, 13222 transcription factor, 12101 2 • J. Neurosci., December 2009 • 29(1): Subject Index tuberous sclerosis complex, 5926 Adenosine triphosphatase extinction and, 10802 tyrosine kinase-dependent, 14451 ATPase activity, 12079 healthy, 8774 visual area V4, 7432 secretory pathway calcium ion-ATPase isoform 1, 12174 neurodegeneration and, 7290 working memory, 14463 sodium/potassium-ATPase, 4498, 8143 neurogenesis and, 4408 Activity dependence, 4004, 14855 sodium/potassium-ATPase ␤3 subunit, 7877 olfactory bulb, 11385 Activity-dependent anchoring, 15613 Adenosine triphosphate, 14713 spatial memory and, 10835 Activity-dependent bulk endocytosis, 7706 taste bud and, 13909 Age-dependent impairment, 10144, 10741 Activity-dependent change, 8764 Adenosine triphosphate-binding cassette transporter A1, 3579 Age-related difference, 15684 Activity-dependent codevelopment, 8816 Adenosine triphosphate metabolite, 14713 Aggregate, fibrillar, 9104 Activity-dependent learning, 6514 Adenosine triphosphate-sensitive potassium ion channel, 7137 Aggregation state, amyloid, 9321 Activity-dependent maturation, 11294 Adenosine triphosphate synthase, 2053 Aggression, 2676 Activity-dependent regulation, 4658, 5425 Adenylate cyclase, 2393 Agnosia, visual form, 5854 Activity-dependent repression, 5425 Adenylyl cyclase Agonism, 13264 Activity-dependent secretion, 23, 14185 AC1, 10835 adenosine receptor, 14015 Activity-dependent synaptic development, 11852 AC5, 12115 selective, 4564 Activity-dependent trafficking, 12845 overexpression of, 10835 Agonist, 1937 Activity-dependent vesicular monoamine transporter, 15878 Adenylyltransferase. See Nicotinamide mononucleotide Agonist binding site, 6022 Activity fluctuation, 13410 adenylyltransferase Agonist potency modulation, 4287 Activity level, 6320 ADHD. See Attention deficit hyperactivity disorder Agonist sensitivity, 13898 Activity pattern, 5516 Adhesion AHP. See Afterhyperpolarization Activity pattern-dependent long-term potentiation, 5587 cell (See Cell adhesion) AIF. See Apoptosis-inducing factor Activity profile, 4664 granule cell, 7439 AIM. See Abnormal involuntary movement Activity propagation, 4782 growth cone, 13981 Aimed scratching movement, 3897 Acuity, tactile spatial, 15756 modifier of cell, 118 Airflow, nasal, 12070 Acutely applied estradiol, 5616 Adhesion kinase, focal, 6649, 8129 AKAP. See A-kinase anchoring protein Aczonin/Piccolo domain, 12584 Adhesive contact, 12449 A-kinase anchoring protein 79/150, 7929 ADAM. See A disintegrin and metalloproteinase A disintegrin and metalloproteinase-10, 4605 Akt, 998, 1093, 1657 Adaptation, 169, 2553, 8996 ADP. See Afterdepolarization phosphatidylinositol 3-kinase/, 775, 4564 behavioral, 2794 Adrenal chromaffin cell, 7137 Akt signal, 6860 of cortical neuron, 13837 Adrenergic innervation, 3613 ALCAM. See Activated leukocyte cell adhesion molecule ␣ dual, 10396 2-Adrenergic receptor, 13264 Alcohol dynamic range, 13797 ␣1b-Adrenergic receptor, 987 addiction to, 8655 face, 12035 Adrenocorticotrophic hormone, 1404 binge drinking, 8655 fast, 4023 Adult, 3276 gating and, 13494 functional magnetic resonance imaging, 1688 Adult avian forebrain, 6558 interoception and, 9582 and inferior colliculus, 5483 Adult avian song nucleus, 4586 withdrawal from, 5389 mechanism, 5009 Adult-born hippocampal neuron, 14484 Aldosterone, 2857 motor, 13019 Adult brain, 5949 Alkalization, 153 night vision and, 5716 Adult hippocampus, 7966 Allan-Herdon-Dudley syndrome, 9439 peripheral, 3067 Adult neuroblast, 5075 Allele, 15810 rapid, 2695 Adult neuroblast plasticity, 5075 Alligator, 7978 saccadic, 250, 11055 Adult neurogenesis, 86, 7966 Allocation, adaptive, 11933 spike frequency, 2626 Adult-onset motoneuron disease, 8236 Allocentric body, 4162 stimulus-specific,
Load more

Recommended publications
  • Long-Term Potentiation Differentially Affects Two Components of Synaptic
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 9346-9350, December 1988 Neurobiology Long-term potentiation differentially affects two components of synaptic responses in hippocampus (plasticity/N-methyl-D-aspartate/D-2-amino-5-phosphonovglerate/facilitation) DOMINIQUE MULLER*t AND GARY LYNCH Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92717 Communicated by Leon N Cooper, September 6, 1988 (receivedfor review June 20, 1988) ABSTRACT We have used low magnesium concentrations ing electrode was positioned in field CAlb between two and the specific antagonist D-2-amino-5-phosphonopentanoate stimulating electrodes placed in fields CAla and CAlc; this (D-AP5) to estimate the effects of long-term potentiation (LTP) allowed us to activate separate inputs to a common pool of on the N-methyl-D-aspartate (NMDA) and non-NMDA recep- target cells. Stimulation voltages were adjusted to produce tor-mediated components of postsynaptic responses. LTP in- field EPSPs of -1.5 mV and did not elicit population spikes duction resulted in a considerably larger potentiation of non- in any of the responses included for data analysis. NMDA as opposed to NMDA receptor-related currents. In- Paired-pulse facilitation was produced by applying two creasing the size of postsynaptic potentials with greater stimulation pulses separated by 30 or 50 ms to the same stimulation currents or with paired-pulse facilitation produced stimulating electrode and LTP was induced by patterned opposite effects; i.e., those aspects ofthe response dependent on burst stimulation-i.e., 10 bursts delivered at 5 Hz, each NMDA receptor's increased to a greater degree than did those burst being composed of four pulses at 100 Hz (see ref.
    [Show full text]
  • Structural Comparison of GLUT1 to GLUT3 Reveal Transport Regulation Mechanism in Sugar Porter Family
    Published Online: 3 February, 2021 | Supp Info: http://doi.org/10.26508/lsa.202000858 Downloaded from life-science-alliance.org on 24 September, 2021 Research Article Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family Taniaˆ Filipa Custódio1,*, Peter Aasted Paulsen1,*, Kelly May Frain1, Bjørn Panyella Pedersen1,2 The human glucose transporters GLUT1 and GLUT3 have a central (M7-12). They are also defined by a signature motif, the “Amotif,” with a role in glucose uptake as canonical members of the Sugar Porter consensus sequence of Gx3[D/E][R/K]xGx[R/K][K/R] (Nishimura et al, (SP) family. GLUT1 and GLUT3 share a fully conserved substrate- 1993). Due to the pseudo-symmetry, the A motif is found twice, located binding site with identical substrate coordination, but differ in the cytosolic loop connecting M2 and M3 of the N-domain and in significantly in transport affinity in line with their physiological the cytosolic loop connecting M8 and M9 of the C-domain. In GLUT1 the ˚ function. Here, we present a 2.4 A crystal structure of GLUT1 in an AmotiftakestheformG84LFVNRFGRR93 and L325FVVERAGRR334.The inward open conformation and compare it with GLUT3 using both A motif is believed to be a key determinant of transport kinetics (Cain structural and functional data. Our work shows that interactions et al, 2000; Jiang et al, 2013; Nomura et al, 2015; Zhang et al, 2015), and it between a cytosolic “SP motif” and a conserved “A motif” sta- may also modulate transport by direct lipid interactions (Martens et al, bilize the outward conformational state and increases substrate 2018).WithintheMFSsuperfamily,theSPfamilyhaveafamily-defining apparent affinity.
    [Show full text]
  • Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes
    Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 1989 Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes Nancy C. Tkacs Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Physiology Commons Recommended Citation Tkacs, Nancy C., "Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes" (1989). Dissertations. 2652. https://ecommons.luc.edu/luc_diss/2652 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1989 Nancy C. Tkacs UBRA~Y·· NEUROPHYSIOLOGY OF FROG DORSAL ROOT AFFERENT FIBERS AND THEIR INTRASPINAL PROCESSES by Nancy C. Tkacs A Dissertation Submitted to the Faculty of the Graduate School of .Loyola University of Chicago in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy April 1989 DEDICATION To Bill, with deep love and gratitude ii ACKNOWLEDG.EMENTS I would like to thank the faculty of the Department of Physiology for the excellent training I have received. I am particularly grateful to Dr. James Filkins for supporting my dissertation research. My thanks also go to Dr. Charles Webber, Dr. David Euler, Dr. David Carpenter, and Dr. Sarah Shefner for serving on my dissertation committee. Their helpful suggestions added much to the research and the dissertation. My gratitude goes to several individuals who unselfishly shared their time, resources, and expertise.
    [Show full text]
  • Action Potential and Synapses
    SENSORY RECEPTORS RECEPTORS GATEWAY TO THE PERCEPTION AND SENSATION Registering of inputs, coding, integration and adequate response PROPERTIES OF THE SENSORY SYSTEM According the type of the stimulus: According to function: MECHANORECEPTORS Telereceptors CHEMORECEPTORS Exteroreceptors THERMORECEPTORS Proprioreceptors PHOTORECEPTORS interoreceptors NOCICEPTORS STIMULUS Reception Receptor – modified nerve or epithelial cell responsive to changes in external or internal environment with the ability to code these changes as electrical potentials Adequate stimulus – stimulus to which the receptor has lowest threshold – maximum sensitivity Transduction – transformation of the stimulus to membrane potential – to generator potential– to action potential Transmission – stimulus energies are transported to CNS in the form of action potentials Integration – sensory information is transported to CNS as frequency code (quantity of the stimulus, quantity of environmental changes) •Sensation is the awareness of changes in the internal and external environment •Perception is the conscious interpretation of those stimuli CLASSIFICATION OF RECEPTORS - adaptation NONADAPTING RECEPTORS WITH CONSTANT FIRING BY CONSTANT STIMULUS NONADAPTING – PAIN TONIC – SLOWLY ADAPTING With decrease of firing (AP frequency) by constant stimulus PHASIC– RAPIDLY ADAPTING With rapid decrease of firing (AP frequency) by constant stimulus ACCOMODATION – ADAPTATION CHARACTERISTICS OF PHASIC RECEPTORS ALTERATIONS OF THE MEMBRANE POTENTIAL ACTION POTENTIAL TRANSMEMBRANE POTENTIAL
    [Show full text]
  • Activity-Dependent Regulation of Prestin Expression in Mouse Outer Hair Cells
    J Neurophysiol 113: 3531–3542, 2015. First published March 25, 2015; doi:10.1152/jn.00869.2014. Activity-dependent regulation of prestin expression in mouse outer hair cells Yohan Song, Anping Xia, Hee Yoon Lee, Rosalie Wang, Anthony J. Ricci, and John S. Oghalai Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California Submitted 4 November 2014; accepted in final form 19 March 2015 Song Y, Xia A, Lee HY, Wang R, Ricci AJ, Oghalai JS. patch-clamp recording conditions (Kakehata and Santos-Sac- Activity-dependent regulation of prestin expression in mouse outer chi, 1995 and 1996; Santos-Sacchi 1991; Santos-Sacchi et al. hair cells. J Neurophysiol 113: 3531–3542, 2015. First published 1998a). Thus, measuring the NLC is a common way of assess- March 25, 2015; doi:10.1152/jn.00869.2014.—Prestin is a membrane protein necessary for outer hair cell (OHC) electromotility and normal ing the amount of functional prestin within an OHC (Abe et al. 2007; Oliver and Fakler 1999;). hearing. Its regulatory mechanisms are unknown. Several mouse Downloaded from models of hearing loss demonstrate increased prestin, inspiring us to There are many ways to modulate the voltage dependence of investigate how hearing loss might feedback onto OHCs. To test force production by prestin protein within the plasma mem- whether centrally mediated feedback regulates prestin, we developed brane, such as changing the surrounding lipid environment, a novel model of inner hair cell loss. Injection of diphtheria toxin (DT) intracellular Ca2ϩ level, membrane tension, membrane poten- into adult CBA mice produced significant loss of inner hair cells tial, and ionic composition of the intracellular and extracellular without affecting OHCs.
    [Show full text]
  • Fast and Slow Synaptic Potentials Produced Ina Mammalian
    Proc. Nat!. Acad. Sci. USA Vol. 83, pp. 1941-1944, March 1986 Neurobiology Fast and slow synaptic potentials produced in a mammalian sympathetic ganglion by colon distension (visceral afferent/inferior mesenteric ganglion/noncholinergic) STEPHEN PETERS AND DAVID L. KREULEN Department of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724 Communicated by C. Ladd Prosser, November 1, 1985 ABSTRACT Radial distension of the large intestine pro- way also comprises noncholinergic fibers; indeed, it remains duced a slow depolarization in a population of neurons in the to be determined whether noncholinergic slow EPSPs even inferior mesenteric ganglion of the guinea pig. The slow occur physiologically. potentials often occurred simultaneously with cholinergic fast We report here the discovery of a noncholinergic sensory potentials [(excitatory postsynaptic potentials (EPSPs)] yet pathway that projects from the distal colon to the inferior persisted in the presence of nicotinic and muscarinic choliner- mesenteric ganglion (1MG) of the guinea pig. This pathway, gic antagonists when all fast EPSPs were absent. The amplitude activated by colon distension, produces noncholinergic slow of the distension-induced noncholinergic slow depolarization depolarizations resembling nerve-evoked slow EPSPs in increased with increasing distension pressure. For distensions sympathetic ganglion cells. Often, distension of the colon of 1-min duration at pressures of 10-20 cm of water, the mean produced both an increase in cholinergic EPSPs and a slow depolarization amplitude was 3.4 mV. The slow depolarization depolarization, suggesting a simultaneous action of two was associated with an increase in membrane resistance, and cell. The prolonged periods ofcolon distension resulted in a tachyphylax- different neurotransmitters on a single ganglion is of the depolarization.
    [Show full text]
  • 2.1 Drosophila Melanogaster
    Overend, Gayle (2010) Drosophila as a model for the Anopheles Malpighian tubule. PhD thesis, University of Glasgow. http://theses.gla.ac.uk/1604/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Drosophila as a model for the Anopheles Malpighian tubule A thesis submitted for the degree of Doctor of Philosophy at the University of Glasgow Gayle Overend Integrative and Systems Biology Faculty of Biomedical and Life Sciences University of Glasgow Glasgow G11 6NU UK August 2009 2 The research reported within this thesis is my own work except where otherwise stated, and has not been submitted for any other degree. Gayle Overend 3 Abstract The insect Malpighian tubule is involved in osmoregulation, detoxification and immune function, physiological processes which are essential for insect development and survival. As the Malpighian tubules contain many ion channels and transporters, they could be an effective tissue for targeting with novel pesticides to control populations of Diptera. Many of the insecticide compounds used to control insect pest species are no longer suited to their task, and so new means of control must be found.
    [Show full text]
  • HER Inhibitor Promotes BRAF/MEK Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Harboring BRAFV600E
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 12), pp: 19843-19854 Research Paper HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E Lingxiao Cheng1,*, Yuchen Jin1,*, Min Liu1, Maomei Ruan2, Libo Chen1 1Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China 2Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China *Co-first authors Correspondence to: Libo Chen, email: [email protected] Keywords: papillary thyroid cancer, redifferentiation, iodine, glucose, dabrafenib Received: October 20, 2016 Accepted: January 24, 2017 Published: February 28, 2017 ABSTRACT Redifferentiation therapy with BRAF/MEK inhibitors to facilitate treatment with radioiodine represents a good choice for radioiodine-refractory differentiated thyroid carcinoma, but recent initial clinical outcomes were modest. MAPK rebound caused by BRAF/MEK inhibitors-induced activation of HER2/HER3 is a resistance mechanism, and combination with HER inhibitor to prevent MAPK rebound may sensitize BRAFV600E- mutant thyroid cancer cells to redifferentiation therapy. To evaluate if inhibiting both BRAF/MEK and HER can produce stronger redifferetiation effect, we tested the effects of BRAF/MEK inhibitor dabrafenib/selumetinib alone or in combination with HER inhibitor lapatinib on the expression and function of iodine- and glucose-handling genes in BRAFV600E-positive BCPAP and K1 cells, using BHP 2-7 cells harboring RET/ PTC1 rearrangement as control. Herein, we showed that lapatinib prevented MAPK rebound and sensitized BRAFV600E-positive papillary thyroid cancer cells to BRAF/ MEK inhibitors. Dabrafenib/selumetinib alone increased iodine-uptake and toxicity and suppressed glucose-metablism in BRAFV600E-positive papillary thyroid cancer cells.
    [Show full text]
  • Glucose Transporter 3 Is Essential for the Survival of Breast Cancer Cells in the Brain
    cells Article Glucose Transporter 3 Is Essential for the Survival of Breast Cancer Cells in the Brain Min-Hsun Kuo 1,2, Wen-Wei Chang 3 , Bi-Wen Yeh 4,5, Yeh-Shiu Chu 6 , Yueh-Chun Lee 7 and Hsueh-Te Lee 1,2,6,8,* 1 Taiwan International Graduate Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei 11529, Taiwan; [email protected] 2 Institute of Anatomy & Cell Biology, National Yang-Ming University, Taipei 11202, Taiwan 3 School of Biomedical Sciences, Chung Shan Medical University, Taichung 40201, Taiwan; [email protected] 4 Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; [email protected] 5 Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan 6 Brain Research Center, National Yang-Ming University, Taipei 11202, Taiwan; [email protected] 7 Department of Radiation Oncology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan; [email protected] 8 Taiwan International Graduate Program in Interdisciplinary Neuroscience, National Yang-Ming University and Academia Sinica, Taipei 11529, Taiwan * Correspondence: [email protected]; Tel.: +886-2-28267073; Fax: +886-2-2821-2884 Received: 15 October 2019; Accepted: 2 December 2019; Published: 4 December 2019 Abstract: Breast cancer brain metastasis commonly occurs in one-fourth of breast cancer patients and is associated with poor prognosis. Abnormal glucose metabolism is found to promote cancer metastasis. Moreover, the tumor microenvironment is crucial and plays an active role in the metabolic adaptations and survival of cancer cells. Glucose transporters are overexpressed in cancer cells to increase glucose uptake.
    [Show full text]
  • Distribution of Glucose Transporters in Renal Diseases Leszek Szablewski
    Szablewski Journal of Biomedical Science (2017) 24:64 DOI 10.1186/s12929-017-0371-7 REVIEW Open Access Distribution of glucose transporters in renal diseases Leszek Szablewski Abstract Kidneys play an important role in glucose homeostasis. Renal gluconeogenesis prevents hypoglycemia by releasing glucose into the blood stream. Glucose homeostasis is also due, in part, to reabsorption and excretion of hexose in the kidney. Lipid bilayer of plasma membrane is impermeable for glucose, which is hydrophilic and soluble in water. Therefore, transport of glucose across the plasma membrane depends on carrier proteins expressed in the plasma membrane. In humans, there are three families of glucose transporters: GLUT proteins, sodium-dependent glucose transporters (SGLTs) and SWEET. In kidney, only GLUTs and SGLTs protein are expressed. Mutations within genes that code these proteins lead to different renal disorders and diseases. However, diseases, not only renal, such as diabetes, may damage expression and function of renal glucose transporters. Keywords: Kidney, GLUT proteins, SGLT proteins, Diabetes, Familial renal glucosuria, Fanconi-Bickel syndrome, Renal cancers Background Because glucose is hydrophilic and soluble in water, lipid Maintenance of glucose homeostasis prevents pathological bilayer of plasma membrane is impermeable for it. There- consequences due to prolonged hyperglycemia or fore, transport of glucose into cells depends on carrier pro- hypoglycemia. Hyperglycemia leads to a high risk of vascu- teins that are present in the plasma membrane. In humans, lar complications, nephropathy, neuropathy and retinop- there are three families of glucose transporters: GLUT pro- athy. Hypoglycemia may damage the central nervous teins, encoded by SLC2 genes; sodium-dependent glucose system and lead to a higher risk of death.
    [Show full text]
  • IGF-I Increases the Recruitment of GLUT4 and GLUT3 Glucose
    European Journal of Endocrinology (2008) 158 361–366 ISSN 0804-4643 CLINICAL STUDY IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism George Dimitriadis1, Eirini Maratou2, Eleni Boutati1, Anastasios Kollias1, Katerina Tsegka1, Maria Alevizaki3, Melpomeni Peppa1, Sotirios A Raptis1,2 and Dimitrios J Hadjidakis1 1Second Department of Internal Medicine, Research Institute and Diabetes Center,University General Hospital ‘Attikon’, Athens University, 1 Rimini Street, 12462 Haidari, Greece, 2Hellenic National Center for Research, Prevention and Treatment of Diabetes Mellitus and its Complications, 10675 Athens, Greece and 3Department of Clinical Therapeutics, 11528 Athens University, Athens, Greece (Correspondence should be addressed to G Dimitriadis; Email: [email protected], [email protected]) Abstract Objective: In hyperthyroidism, tissue glucose disposal is increased to adapt to high energy demand. Our aim was to examine the regulation of glucose transporter (GLUT) isoforms by IGF-I in monocytes from patients with hyperthyroidism. Design and methods: Blood (20 ml) was drawn from 21 healthy and 10 hyperthyroid subjects. The abundance of GLUT isoforms on the monocyte plasma membrane was determined in the absence and presence of IGF-I (0.07, 0.14, and 0.7 nM) using flow cytometry. Anti-CD14-phycoerythrin monocional antibody was used for monocyte gating. GLUT isoforms were determined after staining the cells with specific antisera to GLUT3 and GLUT4. Results: In monocytes from the euthyroid subjects, IGF-I increased the abundance of GLUT3 and GLUT4 on the monocyte surface by 25 and 21% respectively (P!0.0005 with repeated measures ANOVA). Hyperthyroidism increased the basal monocyte surface GLUT3 and GLUT4; in these cells, IGF-I had a marginal but highly significant effect (PZ0.003, with repeated measures ANOVA) on GLUT3 (11%) and GLUT4 (10%) translocation on the plasma membrane.
    [Show full text]
  • Dopaminergic Loss of Cyclin-Dependent Kinase-Like 5 Recapitulates Methylphenidate-Remediable Hyperlocomotion in Mouse Model of CDKL5 Deficiency Disorder
    Dopaminergic loss of cyclin-dependent kinase-like 5 recapitulates methylphenidate-remediable hyperlocomotion in mouse model of CDKL5 deficiency disorder Downloaded from https://academic.oup.com/hmg/article-abstract/doi/10.1093/hmg/ddaa122/5863032 by University of Exeter user on 26 June 2020 Cian-Ling Jhang1, Hom-Yi Lee3,4, Jinchung Chen5, Wenlin Liao1,2 * 1 Institute of Neuroscience, 2 Research Center for Mind, Brain and Learning, National Cheng-Chi University, Taipei 116, Taiwan 3 Department of Psychology, 4 Department of Speech Language Pathology and Audiology, Chung Shan Medical University, Taichung 402, Taiwan 5 Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan 333, Taiwan UNCORRECTED MANUSCRIPT © The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected] page 1 Downloaded from https://academic.oup.com/hmg/article-abstract/doi/10.1093/hmg/ddaa122/5863032 by University of Exeter user on 26 June 2020 * To whom correspondence should be addressed: Wenlin Liao, PhD Associate Professor Institute of Neuroscience, National Cheng-Chi University 64, Sec. 2, Chi-Nan Road, Wen-Shan District Taipei 116, Taiwan Phone: 886-2-29393091 ext. 89621 UNCORRECTEDEmail: [email protected] MANUSCRIPT page 2 ABSTRACT Cyclin-dependent kinase-like 5 (CDKL5), a serine-threonine kinase encoded by an X-linked gene, is highly expressed in mammalian forebrain. Mutations in this gene Downloaded from https://academic.oup.com/hmg/article-abstract/doi/10.1093/hmg/ddaa122/5863032 by University of Exeter user on 26 June 2020 cause CDKL5 deficiency disorder, a neurodevelopmental encephalopathy characterized by early-onset seizures, motor dysfunction and intellectual disability.
    [Show full text]